NVCR logo

NVCR
NovoCure Ltd

7,735
Mkt Cap
$2.08B
Volume
848,886.00
52W High
$20.06
52W Low
$9.82
PE Ratio
-11.71
NVCR Fundamentals
Price
$17.96
Prev Close
$17.90
Open
$17.98
50D MA
$13.59
Beta
1.51
Avg. Volume
1.41M
EPS (Annual)
-$1.22
P/B
6.29
Rev/Employee
$408,319.63
$1,232.17
Loading...
Loading...

About

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
1,605

Frequently Asked Questions

What is Market Cap of NovoCure Ltd?
What is the 52-week high for NovoCure Ltd?
What is the 52-week low for NovoCure Ltd?
What is NovoCure Ltd stock price today?
What was NovoCure Ltd stock price yesterday?
What is the PE ratio of NovoCure Ltd?
What is the Price-to-Book ratio of NovoCure Ltd?
What is the 50-day moving average of NovoCure Ltd?
How many employees does NovoCure Ltd have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available